Press "Enter" to skip to content

Dr. Reddy’s Laboratories announces the re-launch of Zenatane in the US market

Dr. Reddy’s Laboratories Ltd. today announced the re-launch of Zenatane (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg a therapeutic equivalent generic version of Accutane, approved by the USFDA

Original source:

Also Read:   Glenmark gets USFDA nod for acne treatment drug